Sort   by:  
 Page size 
ProteomicsAnalyzing Bioactive Effects of the Minor Hop Compound Xanthohumol C on Human Breast Cancer Cells Using Quantitative Proteomics
We provide label-free data-dependent acquisition proteomics data of mcf-7 breast cancer cell lines treated with the pure minor hop compounds xanthohumol and xanthohumol c.
ORGANISM(S): Homo sapiens (Human) 
2019-03-05 | PXD010785 | Pride
Cancer Minor hop compounds Mcf-7 Xanthohumol c Human Lc-ms/ms Bioactivity 
ProteomicsXanthohumol Activity-Based Probes Targeting Flavonoid Catabolism
Xanthohumol, the principle prenylflavonoid found in hops (Humulus lupulus), is a potential anti-inflammatory agent in the gut. To investigate the interactions between xanthohumol and catabolic gut bacteria, and its role in the anti-inflammatory pathway, a suite of xanthohumol-derived activity-based ...
ORGANISM(S): Eubacterium Ramulus (ncbitaxon:39490) Escherichia Coli (ncbitaxon:562) 
2022-02-04 | MSV000088789 | MassIVE
ProteomicsProteomic Antibacterial Characterization of Flavonoid Xanthohumol and probiotic Clostridium butyricum on Pathogenic Clostridioides difficile
In this study, we evaluated the antimicrobial properties of XN and C. butyricum culture supernatant (CBs) against C. difficile, focusing on their ability to reduce C. difficile adhesion, inhibit growth, and restrict toxin production. Using a dextran sulfate sodium (DSS)-induced Caco-2 intestinal epi...
ORGANISM(S): Clostridioides Difficile 70-100-2010 Clostridioides Difficile Atcc 9689 = Dsm 1296 
2025-10-21 | PXD069714 |
UnknownXanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis.
Not available
S-EPMC7196271 | biostudies-literature
MetabolomicsThe effects of oligomycin administration and glutamine deprivation on metabolic profile of MCF7 breast cancer cell line measured using [1,2-13C2]-D-glucose and [U-13C5]-L-glutamine as tracers
This study aims to establish a comprehensive, genome-scale metabolic model (GSMM) combining different omics data of different regulatory levels of breast cancer cells in order to elucidate the way that these regulatory levels affect or determine each other. Together with transcriptomics, proteomics ...
2021-01-18 | MTBLS183 | MetaboLights
UnknownAnalyzing bioactive effects of the minor hop compound xanthohumol C on human breast cancer cells using quantitative proteomics.
Not available
S-EPMC6420031 | biostudies-literature
UnknownXanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice.
Not available
S-EPMC3500296 | biostudies-literature
UnknownXanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.
Not available
S-EPMC11519634 | biostudies-literature
UnknownTotal synthesis of [13 C]2 -, [13 C]3 -, and [13 C]5 -isotopomers of xanthohumol, the principal prenylflavonoid from hops.
Not available
S-EPMC5832448 | biostudies-literature
UnknownThe Bioavailability of Xanthohumol in Humans and the Influence of Formulation and Dose: Randomized Controlled Trial Data.
Not available
S-EPMC12925386 | biostudies-literature
Sort   by:  
 Page size